The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Paclitaxel nanoparticles for the potential treatment of brain tumors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeAngelis, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440207 · Cited by 1,663
Sweatt, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00054.x · Cited by 1,131
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Identification of prognostic factors in patients with brain metastases: a review of 1292 patients
Lagerwaard, F., Levendag, P., Nowak, P. C. M., Eijkenboom, W. H., Hanssens, P. J., & Schmitz, P. M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00442-8 · Cited by 721
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
An in situ brain perfusion technique to study cerebrovascular transport in the rat
Takasato, Y., Rapoport, S. I., & Smith, Q. R. (1984) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1984.247.3.h484 · Cited by 541
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
Fellner, S., Bauer, B., Miller, D. S., Schaffrik, M., Fankhänel, M., Spruß, T., Bernhardt, G., Graeff, C., Färber, L., Gschaidmeier, H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15451 · Cited by 359
Brain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 259
Self-citationIncreased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.
Kemper, E. M., van Zandbergen, A. E., Cleypool, C. G. J., Mos, H. A., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2003) · PubMed · Cited by 243
Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
Reversal of multidrug resistance by surfactants
Woodcock, D., Linsenmeyer, M., Chojnowski, G., Kriegler, A., Nink, V, Webster, L., & Sawyer, W. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.217 · Cited by 233
Pharmaceutical aspects of paclitaxel
Panchagnula, R. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00188-4 · Cited by 220
Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology
(1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511570216 · Cited by 183
In Situ Blood–Brain Barrier Transport of Nanoparticles
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003374.58641.62 · Cited by 182
Self-citationWu, L., Smythe, A. M., Stinson, S. F., Mullendore, L. A., Monks, A., Scudiero, D. A., Paull, K. D., Koutsoukos, A. D., Rubinstein, L., & Boyd, M. R. (1992) · PubMed · Cited by 156
DAMASCELLI, B., Cant�, G., Mattavelli, F., Tamplenizza, P., Bidoli, P., Leo, E., Dosio, F., Cerrotta, A., Tolla, G. D., Frigerio, L. F., et al. (2001) · Cancer · Cited by 146
Stein, U., Jürchott, K., Walther, W., Bergmann, S., Schlag, P. M., & Royer, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100311200 · Cited by 145
Do anticancer agents reach the tumor target in the human brain?
Donelli, M. G., Zucchetti, M., & D’Incalci, M. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686291 · Cited by 139
A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors
Stewart, D. J. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052723 · Cited by 131
Paclitaxel (TAXOL®) concentrations in brain tumor tissue
Heimans, J. J., Vermorken, J. B., Wolbers, J. G., Eeltink, C., Meijer, O. W. M., TAPHOORN, M. J. B., & Beijnen, J. H. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058736 · Cited by 131
Tissue distribution, metabolism and excretion of paclitaxel in mice
Sparreboom, A., van Tellingen, O., Nooijen, W. J., & Beijnen, J. H. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199601000-00009 · Cited by 128
The role of chemotherapy in brain metastases
van den Bent, M. J. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00577-x · Cited by 121
Allen, D. D., & Smith, Q. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00093.x · Cited by 118
Self-citationBrain Perfusion Systems for Studies of Drug Uptake and Metabolism in the Central Nervous System
Smith, Q. R. (1996) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-1863-5_15 · Cited by 114
Li, C., Newman, R. A., Wu, Q.-P., Shi, K., Chen, W., Hutto, T. Y., Kan, Z., Brannan, M. D., Charnsangavej, C., & Wallace, S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000168 · Cited by 114
The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.
Gallo, J. M., Li, S., Guo, P., Reed, K., & Ma, J. (2003) · PubMed · Cited by 105
Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and Vinblastine
Drion, N., Lemaire, M., Lefauconnier, J.-M., & Scherrmann, J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041688.x · Cited by 104
Nsereko, S., & Amiji, M. M. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00005-4 · Cited by 98
Lockman, P. R., Koziara, J. M., Roder, K. E., Paulson, J. R., Abbruscato, T. J., Mumper, R. J., & Allen, D. D. (2003) · Pharmaceutical Research · doi:10.1023/a:1023492015851 · Cited by 90
Self-citationGadolinium-Loaded Nanoparticles Engineered from Microemulsion Templates
Oyewumi, M. O., & Mumper, R. J. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120002847 · Cited by 65
Self-citationPolilactofate microspheres for Paclitaxel delivery to central nervous system malignancies.
Li, K. W., Dang, W., Tyler, B., Troiano, G., Tihan, T., Brem, H., & Walter, K. A. (2003) · PubMed · Cited by 65
Rice, A., Michaelis, M. L., Georg, G. I., Liu, Y., Turunen, B. J., & Audus, K. L. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:339 · Cited by 49
Evaluation of blood–brain barrier thiamine efflux using the in situ rat brain perfusion method
Lockman, P. R., Mumper, R. J., & Allen, D. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01888.x · Cited by 43
Self-citationPhysiologically Based Pharmacokinetic Models of 2′,3′-Dideoxyinosine
Kang, H.-J. K., Wientjes, M. G., & Au, J. L. ‐. (1997) · Pharmaceutical Research · doi:10.1023/a:1012002206007 · Cited by 20
Cited by
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Applications of nanoparticles in biology and medicine
Salata, O. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-3 · Cited by 2,327
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Nanotechnology-based drug delivery systems
Suri, S. S., Fenniri, H., & Singh, B. (2007) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-2-16 · Cited by 755
Metadata
- Authors
- Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 99
- Issue
- 2
- Pages
- 259-269
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2059877047
- Cited by
- 299
- References
- 35
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.